Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q3 2022
Institutional positions in Verona Pharma plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 68
- +29 vs. Q2 2022
- Shares held
- 52.1M
- +17.0M (+48.4%) vs. Q2 2022
- Total value
- $529.0M
- +$383.1M (+262.6%) vs. Q2 2022
- New holders
- 35
- 15 more added
- Sold out
- 6
- 7 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 6,050,000 | $61.8M | 1.32% | +950,000+18.6% | Added |
| OrbiMed Advisors LLC | 5,694,841 | $58.2M | 1.16% | 00.0% | Unchanged |
| NEA Management Company, LLC | 5,584,753 | $57.1M | 2.85% | +476,190+9.3% | Added |
| Perceptive Advisors LLC | 5,047,264 | $51.6M | 1.50% | +2,132,118+73.1% | Added |
| Vivo Capital, LLC | 4,249,918 | $43.4M | 4.80% | +1,500,000+54.5% | Added |
| Wellington Management Group LLP | 4,177,276 | $42.7M | 0.01% | +349,127+9.1% | Added |
| Deep Track Capital, LP | 2,829,094 | $28.9M | 1.43% | +2,829,094 | New |
| Fairmount Funds Management LLC | 2,678,982 | $27.4M | 5.05% | +1,752,380+189.1% | Added |
| Abingworth LLP | 2,457,500 | $25.1M | 8.58% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,099,541 | $21.5M | 1.65% | +2,099,541 | New |
| Aisling Capital Management LP | 1,332,485 | $13.6M | 9.04% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 1,324,868 | $13.5M | 2.34% | +1,324,868 | New |
| Foresite Capital Management III, LLC | 1,111,112 | $11.4M | 29.98% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 938,890 | $9.60M | 2.24% | −172,222−15.5% | Reduced |
| Citadel Advisors LLC | 695,260 | $7.11M | 0.01% | +684,511+6,368.1% | Added |
| Adage Capital Partners GP, L.L.C. | 431,816 | $4.41M | 0.01% | +431,816 | New |
| State Street Corp | 449,029 | $4.23M | 0.00% | +449,029 | New |
| FMR LLC | 413,400 | $4.22M | 0.00% | +413,400 | New |
| Altium Capital Management LP | 404,000 | $4.13M | 1.55% | +404,000 | New |
| Woodline Partners LP | 375,033 | $3.83M | 0.06% | −126,425−25.2% | Reduced |
| Two Sigma Investments, LP | 360,550 | $3.69M | 0.01% | +360,550 | New |
| Affinity Asset Advisors, LLC | 350,000 | $3.58M | 1.65% | +350,000 | New |
| Parkman Healthcare Partners LLC | 323,273 | $3.30M | 0.94% | +323,273 | New |
| Janus Henderson Group PLC | 300,000 | $3.07M | 0.00% | +300,000 | New |
| ExodusPoint Capital Management, LP | 239,602 | $2.45M | 0.03% | +239,602 | New |
| Moody Aldrich Partners LLC | 227,989 | $2.33M | 0.48% | +227,989 | New |
| Renaissance Technologies LLC | 210,100 | $2.15M | 0.00% | +181,900+645.0% | Added |
| Two Sigma Advisers, LP | 153,400 | $1.57M | 0.00% | +153,400 | New |
| ACT Capital Management, LLC | 143,500 | $1.47M | 2.02% | +143,500 | New |
| Sphera Funds Management Ltd. | 120,000 | $1.23M | 0.22% | +120,000 | New |
| UBS Oconnor LLC | 111,926 | $1.14M | 0.01% | +111,926 | New |
| Pura Vida Investments, LLC | 100,000 | $1.02M | 0.15% | +100,000 | New |
| Millennium Management LLC | 79,340 | $811.0K | 0.00% | +79,340 | New |
| 1492 Capital Management LLC | 65,862 | $673.0K | 0.49% | +65,862 | New |
| JPMorgan Chase & Co | 63,279 | $647.0K | 0.00% | +63,279 | New |
| Schonfeld Strategic Advisors LLC | 59,000 | $603.0K | 0.01% | +4,700+8.7% | Added |
| Boothbay Fund Management, LLC | 46,799 | $478.0K | 0.02% | +8,519+22.3% | Added |
| US Bancorp | 46,095 | $471.0K | 0.00% | +42,255+1,100.4% | Added |
| Cubist Systematic Strategies, LLC | 42,877 | $438.0K | 0.00% | +42,877 | New |
| Geode Capital Management, LLC | 42,350 | $432.0K | 0.00% | +27,913+193.3% | Added |
| Vanguard Group Inc | 41,704 | $426.0K | 0.00% | +41,704 | New |
| Jump Financial, LLC | 40,800 | $417.0K | 0.02% | +40,800 | New |
| D.A. Davidson & Co. | 40,000 | $409.0K | 0.01% | −4,500−10.1% | Reduced |
| AlphaCentric Advisors LLC | 40,000 | $409.0K | 0.42% | +40,000 | New |
| Goldman Sachs Group Inc | 36,360 | $372.0K | 0.00% | +24,767+213.6% | Added |
| Glenmede Trust Co NA | 30,215 | $308.0K | 0.00% | +30,215 | New |
| Bank of New York Mellon Corp | 24,850 | $254.0K | 0.00% | +24,850 | New |
| Ikarian Capital, LLC | 315,131 | $193.0K | 0.10% | +15,131+5.0% | Added |
| Envestnet Asset Management Inc | 16,192 | $165.0K | 0.00% | +16,192 | New |
| HSBC Holdings PLC | 15,041 | $158.0K | 0.00% | 00.0% | Unchanged |
| Forefront Analytics, LLC | 13,446 | $138.0K | 0.07% | −13,750−50.6% | Reduced |
| SEI Investments Co | 13,460 | $138.0K | 0.00% | +13,460 | New |
| Brinker Capital Investments, LLC | 12,326 | $126.0K | 0.00% | +12,326 | New |
| Group One Trading, L.P. | 5,217 | $53.0K | 0.00% | +5,138+6,503.8% | Added |
| Morgan Stanley | 4,978 | $51.0K | 0.00% | −4,807−49.1% | Reduced |
| Endurance Wealth Management, Inc. | 2,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,380 | $14.0K | 0.00% | −297−17.7% | Reduced |
| Fifth Third Bancorp | 1,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 892 | $9.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 778 | $8.00K | 0.00% | +778 | New |
| Royal Bank of Canada | 726 | $7.00K | 0.00% | +726 | New |
| Federation des caisses Desjardins du Quebec | 650 | $6.64K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 553 | $6.00K | 0.00% | −1,573−74.0% | Reduced |
| Cutler Group LP | 392 | $4.00K | 0.00% | +392 | New |
| Advisor Group Holdings, Inc. | 346 | $3.00K | 0.00% | +346 | New |
| Wells Fargo & Company | 100 | $1.00K | 0.00% | +100 | New |
| BlackRock Inc. | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Novo Holdings A/S | 0 | $0 | 0.00% | −761,205−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −751,905−100.0% | Sold out |
| venBio Partners LLC | 0 | $0 | 0.00% | −161,897−100.0% | Sold out |
| IPG Investment Advisors LLC | 0 | $0 | 0.00% | −11,900−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,866−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Brewin Dolphin Ltd | – | – | – | – | Not filed |